About: Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies
Creator	Fischer, David Berner, Julius Elbrächter, Dennis Fuchs, Tim Grohs, Philipp »more»
source	MedRxiv
abstract	We provide a comparison of general strategies for group testing in view of their application to medical diagnosis in the current COVID-19 pandemic. We find significant efficiency gaps between different group testing strategies in realistic scenarios for SARS-CoV-2 testing, highlighting the need for an informed decision of the pooling protocol depending on estimated prevalence, target specificity, and high- vs. low-risk population. For example, using one of the presented methods, all 1.47 million inhabitants of Munich, Germany, could be tested using only around 141 thousand tests if an infection rate up to 0.4% is assumed. Using 1 million tests, the 6.69 million inhabitants from the city of Rio de Janeiro, Brazil, could be tested as long as the infection rate does not exceed 1%. Altogether this work may help provide a basis for efficient upscaling of current testing procedures, fine grained towards the desired study population, e.g. cross-sectional versus health-care workers and adapted mixtures thereof. For comparative visualization and querying of the precomputed results we provide an interactive web application. The source code for computation is open and freely available.
has issue date	2020-05-05(xsd:dateTime)
bibo:doi	10.1101/2020.04.30.20085290
has license	medrxiv
sha1sum (hex)	c69da9207ff890b47165180141fce9ec4974da7a
schema:url	https://doi.org/10.1101/2020.04.30.20085290
resource representing a document's title	Group testing for SARS-CoV-2 allows for up to 10-fold efficiency increase across realistic scenarios and testing strategies
resource representing a document's body	covid:c69da9207ff890b47165180141fce9ec4974da7a#body_text
is schema:about of	named entity 'infection' named entity 'health-care' named entity 'application' named entity 'testing' named entity 'adapted' »more»

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software